Maynard Um
-
-
-
-
-
-
-
Evercore: ' Latest Survey Work Positions 2026 As Better Year For Biopharma Spending'
-
-
-
-
-
-
-
Benchmark Reiterates Buy Rating on Bio-Techne Corp. (TECH)
-
-
-
-
-
-
-
Bio-Techne expands Oxford Nanopore partnership through 2032
-
-
-
-
-
-
-
Bio-Techne technology used in FDA-approved gene therapy ZEVASKYN
-
-
-
-
-
-
-
Wells Fargo Starts Bio-Techne Corp. (TECH) at Overweight
-
-
-
-
-
-
-
Bio-Techne Corp. (TECH) PT Raised to $80 at RBC Capital as '9% Organic Growth Drives Beat'
-
-
-
-
-
-
-
Bio-Techne (TECH) Sells Selected Fetal Bovine Serum (FBS) Product Rights and Inventory to Gemini Bioproducts
-
404,872 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

